Abstract
Nevin Sanlier, Ebru Ozler, Nurben Karanfil
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Berberine: a novel therapeutic strategy for cancer
10.1002/iub.2350 · 2020
Addressing the preventive and therapeutic perspective of berberine against diabetes
10.1016/j.heliyon.2023.e21233 · 2023
Biological properties and clinical applications of berberine
10.1007/s11684-019-0724-6 · 2020
Studies on synthesis, physicochemical properties, biological activities of two novel berberine-based salts with dl-mandelate and cinnamate anions
10.1016/j.molstruc.2023.136359 · 2023
Development of an innovative berberine food-grade formulation with an ameliorated absorption: in vitro evidence confirmed by healthy human volunteers pharmacokinetic study
10.1155/2021/7563889 · 2021
The anti-cancer mechanisms of berberine: a review
10.2147/cmar.s242329 · 2020
Polylactide-based films incorporated with berberine-physicochemical and antibacterial properties
10.3390/foods12010091 · 2022
Berberine for prevention of dementia associated with diabetes and its comorbidities: a systematic review
10.1016/j.joim.2020.01.004 · 2020
Overall and sex-specific effect of berberine for the treatment of dyslipidemia in adults: a systematic review and meta-analysis of randomized placebo-controlled trials
10.1007/s40265-023-01841-4 · 2023
Regulatory effects of berberine on microRNome in cancer and other conditions
10.1016/j.critrevonc.2017.05.008 · 2017
Berberine as a potential anticancer agent: a comprehensive review
10.3390/molecules26237368 · 2021
Berberine-a promising therapeutic approach to polycystic ovary syndrome in infertile/pregnant women
10.3390/life13010125 · 2023
Research progress on pharmacological effects and bioavailability of berberine
10.1007/s00210-024-03199-0 · 2024
A review of Fibraurea tinctoria and its component, berberine, as an antidiabetic and antioxidant
10.3390/molecules28031294 · 2023
Micro- and nanoencapsulated hybrid delivery system (mnehds): a novel approach for colon-targeted oral delivery of berberine
10.1021/acs.molpharmaceut.0c00970 · 2021
Spray-dried solid lipid nanoparticles for enhancing berberine bioavailability via oral administration
10.2174/0113816128263982231102062745 · 2023
10.1007/978-3-030-75506-5_25
10.1007/978-3-030-75506-5_25 · 2022
Solid lipid nanoformulation of berberine attenuates doxorubicin triggered in vitro inflammation in H9c2 rat cardiomyocytes
10.2174/1386207325666220617113744 · 2022
Chitosan-coated solid lipid nano-encapsulation improves the therapeutic antiairway inflammation effect of berberine against COPD in cigarette smoke-exposed rats
10.1155/2022/8509396 · 2022
Bioavailability and hepatoprotection enhancement of berberine and its nanoparticles prepared by liquid antisolvent method
10.1016/j.sjbs.2020.10.006 · 2021
Development of natural polysaccharide-based nanoparticles of berberine to enhance oral bioavailability: formulation, optimization, ex vivo, and in vivo assessment
10.3390/polym13213833 · 2021
Optimization of hyaluronate-based liposomes to augment the oral delivery and the bioavailability of berberine
10.3390/ma14195759 · 2021
Membrane composition allows the optimization of berberine encapsulation in liposomes
10.1021/acs.molpharmaceut.4c00830 · 2024
Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity
10.1038/s41401-018-0183-7 · 2019
Monodisperse microparticles loaded with the self-assembled berberine-phospholipid complex-based phytosomes for improving oral bioavailability and enhancing hypoglycemic efficiency
10.1016/j.ejpb.2016.03.019 · 2016
Co-encapsulation of berberine and piperine in coaxial electrosprayed chitosan nanoparticles for sustained release and improved berberine bioavailability
10.1007/s11696-024-03381-x · 2024
Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice
10.1186/s12951-021-00979-1 · 2021
Antiviral activity of berberine
10.1007/s00705-020-04706-3 · 2020
Pharmacokinetics and pharmacological activities of berberine in diabetes mellitus treatment
10.1155/2021/9987097 · 2021
Pharmacokinetics and excretion of berberine and its nine metabolites in rats
10.3389/fphar.2020.594852 · 2021
Pharmacokinetics, tissue distribution and excretion of demethyleneberberine, a metabolite of berberine, in rats and mice
10.3390/molecules28237725 · 2023
Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders
10.1007/s43440-021-00348-7 · 2022
A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome
10.22038/ijbms.2017.8682 · 2017
Structure, diversity, and composition of bacterial communities in rhizospheric soil of coptis chinensis franch under continuously cropped fields
10.3390/d12020057 · 2020
Therapeutic effect of berberine on metabolic diseases: both pharmacological data and clinical evidence
10.1016/j.biopha.2020.110984 · 2021
Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders
10.3389/fphar.2018.00557 · 2018
Recent advances of application of berberin on phospholipase a2 (pla2): a novel and potent therapeutic inhibitor in targeting lung cancer
10.1016/b978-0-323-95699-4.00012-8 · 2023
Nano formulation of berberine (Brb): transforming a natural alkaloid into advanced therapeutics
10.7324/japs.2024.657635 · 2024
Application of berberine on skin diseases: a review
10.52711/0975-4377.2022.00050 · 2022
Elucidating berberine’s therapeutic and photosensitizer potential through nanomedicine tools
10.3390/pharmaceutics15092282 · 2023
Estimation of heavy metals in different Berberis species and its market samples
10.1007/s10661-006-7395-x · doi-reference
Improved up-and-down procedure for acute toxicity measurement with reliable LD50 verified by typical toxic alkaloids and modified Karber method
10.1186/s40360-021-00541-7 · doi-reference
Cardiovascular effects of berberine: a review of the literature
10.14200/jrm.2017.6.0100 · doi-reference
Toxicological effects of berberine and sanguinarine
10.3389/fmolb.2018.00021 · doi-reference
Berberine influences multiple diseases by modifying gut microbiota
10.3389/fnut.2023.1187718 · doi-reference
Inflammatory markers and noncoding-RNAs responses to low and high compressions of HIIT with or without berberine supplementation in middle-aged men with prediabetes
10.14814/phy2.16146 · doi-reference
The effects of active ingredients of barberry root (berberine) on glycemic control and insulin resistance in type 2 diabetic patients
10.5812/jjnpp.64180 · doi-reference
Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients
10.4103/jrms.jrms_1078_17 · doi-reference
Comparative effects of Gymnema sylvestre and berberine on adipokines, body composition, and metabolic parameters in obese patients: a randomized study
10.3390/nu16142284 · doi-reference
Berberine ameliorates glucose metabolism in diabetic rats through the alpha7 nicotinic acetylcholine receptor-related cholinergic anti-inflammatory pathway
10.1055/a-1385-8015 · doi-reference
Berberine improves diabetic encephalopathy through the SIRT1/ER stress pathway in db/db mice
10.1089/rej.2017.1972 · doi-reference
Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats
10.4103/pm.pm_584_16 · doi-reference
Effects of berberine on growth, liver histology, and expression of lipid-related genes in blunt snout bream (Megalobrama amblycephala) fed high-fat diets
10.1007/s10695-018-0536-7 · doi-reference
Berberine ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats via activation of SIRT3/AMPK/ACC pathway
10.1007/s11596-019-1997-3 · doi-reference
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
10.1186/s12902-017-0165-7 · doi-reference
Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth
10.1038/labinvest.2017.71 · doi-reference
Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells
10.1038/onc.2017.296 · doi-reference
Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence
10.1016/j.actbio.2019.09.034 · doi-reference
Regulation of Akt/FoxO3a/Skp2 axis is critically involved in berberine-induced cell cycle arrest in hepatocellular carcinoma cells
10.3390/ijms19020327 · doi-reference
Berberine inhibits the apoptosis-induced metastasis by suppressing the iPLA2/LOX-5/LTB4 pathway in hepatocellular carcinoma
10.2147/ott.s243357 · doi-reference
Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer
10.1111/cpr.12393 · doi-reference
Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs
10.1111/jcmm.14560 · doi-reference
Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
10.1016/j.pharep.2018.07.005 · doi-reference
Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK-HIF-1α
10.7150/ijbs.18969 · doi-reference
Berberine inhibits MDA-MB-231 cells by attenuating their inflammatory responses
10.1155/2020/3617514 · doi-reference
Berberine enhances posttranslational protein stability of p21/cip1 in breast cancer cells via down-regulation of Akt
10.1007/s11010-019-03529-4 · doi-reference
Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis
10.1111/bph.14935 · doi-reference
Berberine attenuates inflammation and oxidative stress and modulates lymphocyte E-NTPDase in acute hyperlipidemia
10.1002/ddr.22166 · doi-reference
Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway
10.1016/j.bbrc.2018.03.003 · doi-reference
Berberine ameliorates blockade of autophagic flux in the liver by regulating cholesterol metabolism and inhibiting COX2-prostaglandin synthesis
10.1038/s41419-018-0890-5 · doi-reference
Colon-targeted self-assembled nanoparticles loaded with berberine double salt ameliorate ulcerative colitis by improving intestinal mucosal barrier and gut microbiota
10.1016/j.colsurfb.2024.114353 · doi-reference
Berberine alleviates inflammation and suppresses PLA2-COX-2-PGE2-E. P2 pathway through targeting gut microbiota in DSS-induced ulcerative colitis
10.1016/j.bbrc.2023.149411 · doi-reference
Berberine alleviates enterotoxigenic Escherichia coli-induced intestinal mucosal barrier function damage in a piglet model by modulation of the intestinal microbiome
10.3389/fnut.2024.1494348 · doi-reference
Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation
10.1038/s41401-020-00601-4 · doi-reference
Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice
10.1016/j.biopha.2019.109131 · doi-reference
Effect of berberine on spleen transcriptome and gut microbiota composition in experimental autoimmune uveitis
10.1016/j.intimp.2020.106270 · doi-reference
A holistic view of berberine inhibiting intestinal carcinogenesis in conventional mice based on microbiome-metabolomics analysis
10.3389/fimmu.2020.588079 · doi-reference
Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats
10.1007/s00253-019-10307-1 · doi-reference
Berberine damages the cell surface of methicillin-resistant Staphylococcus aureus
10.3389/fmicb.2020.00621 · doi-reference
Berberine pharmacology and the gut microbiota: a hidden therapeutic link
10.1016/j.phrs.2020.104722 · doi-reference